Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients
Authors
Keywords
Protease inhibitor therapy, HIV-1, Antiretroviral therapy, Highly-active antiretroviral therapy, Viral load, Cholesterol, Toxicity, Reverse transcriptase inhibitors
Journal
PLoS One
Volume 11, Issue 2, Pages e0148231
Publisher
Public Library of Science (PLoS)
Online
2016-02-06
DOI
10.1371/journal.pone.0148231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of Cardiovascular Events Associated With Current Exposure to HIV Antiretroviral Therapies in a US Veteran Population
- (2015) Manisha Desai et al. CLINICAL INFECTIOUS DISEASES
- Antiretroviral Treatment of Adult HIV Infection
- (2014) Huldrych F. Günthard et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study
- (2014) C. Katlama et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial
- (2014) Pedro Cahn et al. LANCET INFECTIOUS DISEASES
- Treatment of HIV in the CNS: Effects of Antiretroviral Therapy and the Promise of Non-Antiretroviral Therapeutics
- (2014) Michael J. Peluso et al. Current HIV/AIDS Reports
- Nevirapine-raltegravir combination, a NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients
- (2013) Véronique Reliquet et al. ANTIVIRAL THERAPY
- Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya
- (2013) L. Ryom et al. JOURNAL OF INFECTIOUS DISEASES
- Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review
- (2013) Clay Bavinger et al. PLoS One
- Switching Tenofovir/Emtricitabine plus Lopinavir/r to Raltegravir plus Darunavir/r in Patients with Suppressed Viral Load Did Not Result in Improvement of Renal Function but Could Sustain Viral Suppression: A Randomized Multicenter Trial
- (2013) Takeshi Nishijima et al. PLoS One
- The history of antiretroviral therapy and of its implementation in resource-limited areas of the world
- (2012) Stefano Vella et al. AIDS
- A Switch in Therapy to a Reverse Transcriptase Inhibitor Sparing Combination of Lopinavir/Ritonavir and Raltegravir in Virologically Suppressed HIV-Infected Patients: A Pilot Randomized Trial to Assess Efficacy and Safety Profile: The KITE Study
- (2012) Ighovwerha Ofotokun et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results
- (2012) Michael J. Kozal et al. HIV CLINICAL TRIALS
- No Association of Abacavir Use With Myocardial Infarction
- (2012) Xiao Ding et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen
- (2012) J. Burgos et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Bone Loss in the HIV-Infected Patient: Evidence, Clinical Implications, and Treatment Strategies
- (2012) Vanessa Walker Harris et al. JOURNAL OF INFECTIOUS DISEASES
- The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?
- (2012) Andrew Carr et al. PLOS MEDICINE
- Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons
- (2011) Andy I Choi et al. AIDS
- Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262)
- (2011) Babafemi Taiwo et al. AIDS
- Abacavir use and cardiovascular disease events
- (2011) Mario Cruciani et al. AIDS
- Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence
- (2011) Andrew M. Hall et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- HIV Infection, Immune Suppression, and Uncontrolled Viremia Are Associated With Increased Multimorbidity Among Aging Injection Drug Users
- (2011) M. L. Salter et al. CLINICAL INFECTIOUS DISEASES
- Examination of Noninferiority, Safety, and Tolerability of Lopinavir/ritonavir and Raltegravir Compared with Lopinavir/ritonavir and Tenofovir/ Emtricitabine in Antiretroviral-Naïve Subjects: The PROGRESS Study, 48-Week Results
- (2011) Jacques Reynes et al. HIV CLINICAL TRIALS
- Higher Rates of Bone Loss in Postmenopausal HIV-Infected Women: A Longitudinal Study
- (2011) Michael T. Yin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
- (2011) Grace A. McComsey et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of Protease Inhibitor Monotherapy versus Combination Antiretroviral Maintenance Therapy: A Meta-Analysis
- (2011) Sandra Mathis et al. PLoS One
- Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
- (2010) Amanda Mocroft et al. AIDS
- Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
- (2009) Richard H Haubrich et al. AIDS
- Is Dual Therapy With Raltegravir and Protease Inhibitors a Feasible Option in Rescue Strategy in HIV-1 Infection?
- (2009) Amedeo Ferdinando Capetti et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A Randomized, Open-Label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor-Sparing Regimen in Antiretroviral-Naive HIV-Infected Patients
- (2009) Marianne Harris et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
- (2009) Signe Westring Worm et al. JOURNAL OF INFECTIOUS DISEASES
- Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss
- (2009) Marit G. A. van Vonderen et al. PLoS One
- Class-Sparing Regimens for Initial Treatment of HIV-1 Infection
- (2008) Sharon A. Riddler et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started